Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INVAC-1 |
Trade Name | |
Synonyms | |
Drug Descriptions |
INVAC-1 is a cancer vaccine comprised of a DNA plasmid engineered to encode a catalytically inactive human TERT (hTERT) linked to ubiquitin for rapid proteosomal degradation, which potentially induces an anti-tumor immune response and cytotoxicity against TERT-expressing cancer cells and delays tumor growth (PMID: 27141336, PMID: 31558479). |
DrugClasses | |
CAS Registry Number | 1708137-44-3 |
NCIT ID | C119737 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INVAC-1 | INVAC-1 | 0 | 1 |